Aimgrow Biotech

Aimgrow Biotech is a biotechnology company headquartered in Suzhou, China, dedicated to the discovery of innovative drugs targeting G protein-coupled receptors (GPCRs). The company utilizes a proprietary technology platform that combines high-throughput screening, structural biology, and computational chemistry to address complex membrane protein targets. Their research pipeline primarily focuses on therapeutic areas such as metabolic disorders, inflammatory diseases, and oncology. By employing advanced protein stabilization techniques and Cryo-electron microscopy (Cryo-EM), Aimgrow aims to overcome the historical challenges associated with GPCR drug development. The company is positioned as an early-stage innovator within the BioBAY ecosystem, seeking to deliver first-in-class or best-in-class therapeutic candidates.